With courts striking down the government's monopoly on supplying medical marijuana, private growers are clamouring to capitalize on pot's commercial potential

DUNCAN - Eric Nash can barely contain his excitement waiting to hear from Health Canada whether he can start growing marijuana for 250 patients.

That would be just the start. There are tens of thousands more who are ailing across the country clamouring for his organic B.C. bud.

"There is a great opportunity here for the government to collect significant tax revenue currently being lost to the street market," Nash, one of the best-known legal cannabis producers, enthused.

"With the current global financial crisis, this court ruling is certainly a bright light in dark economic times. We're just waiting for clarification. I figure our production would increase significantly from several pounds to 150 pounds or more immediately."

Now that the Federal Court of Appeal has struck down the government's monopoly on supplying medical marijuana, Nash believes commercial agricultural production of pot is around the corner and the sky's the limit.

His local company, Island Harvest, has cleared the industrial security regulatory hurdles so the company meets the standards set by Ottawa to grow the much-demonized plant.

"Our vision is to have a sustainable commercial agriculture operation," he said. "There's no reason we can't achieve that. Look at the number of compassion clubs, look at the number of people using marijuana to relieve a headache or pre-menstrual cramps!"

More and more research is supporting previous anecdotal evidence that cannabis may have a wide range of therapeutic uses from the treatment of Alzheimer's, depression, glaucoma, epilepsy and cancer to HIV/AIDS, hepatitis and ADD/ADHD. Its most ardent promoters say cannabis may be an addition to the modern pharmacopeia that rivals Aspirin in the breadth of its applications.

It doesn't take a genius to realize the potential profits are staggering.

Until now, the government's poorly administered medical program has artificially depressed that market by making it difficult for patients to qualify, supplied what many consider poor-quality marijuana and imposed an arbitrary restriction on qualified licensed growers to supplying only two patients.

Doctors, too, have exacerbated the situation with their reluctance to prescribe marijuana, claiming they have no guide on dosage or the usual pharmaceutical medical studies to rely on. That is changing, slowly.

Nash explained there have been three relatively recent, serious analyses of the medical marijuana market, which give an idea of its scope and potential.

The Canadian Medical Association Journal did a survey in 2000 and estimated the number of self-medicating marijuana patients to be 1.9 per cent of the population; a Price Waterhouse report prepared for Health Canada two years later concluded it was more like four per cent of the population, and a report in 2004 by a member of the federal government's advisory committee on pot suggested the reality was closer to seven per cent.

(Health Canada, after eight years, has issued roughly 2,500 exemption permits to needy patients.)